Holen Sie sich die Stockscreener-App
72.88
1.69%
1.21
Handel nachbörslich:
73.31
0.43
+0.59%
Schlusskurs vom Vortag:
$71.67
Offen:
$72.04
24-Stunden-Volumen:
1.54M
Relative Volume:
1.02
Marktkapitalisierung:
$8.58B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
29.87
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
-3.15%
1M Leistung:
+12.75%
6M Leistung:
+3.27%
1J Leistung:
-3.10%
1-Tages-Spanne:
$72.04
$73.15
1-Wochen-Bereich:
$71.27
$75.51
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
72.88 | 8.44B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
805.37 | 102.41B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
335.31 | 68.03B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
199.71 | 48.74B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.39 | 790.85M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein Expands Partnership with vVARDIS - Dentistry Today
2025 Healthy Outcomes Conference: Henry Schein Canada reducing disability leave claims with wellness program - Benefits Canada.com
Curodont Drill-Free Caries Treatment to Be Distributed by Henry Schein Across U.S. Dental Market - Orthodontic Products
HSIC Stock Benefits From Expanded Partnership With vVARDIS - TradingView
A Closer Look at Henry Schein (HSIC) Valuation Following Recent Share Price Momentum - Yahoo Finance
Henry Schein expands vVARDIS distribution deal for drill-free cavity treatment - Investing.com Nigeria
Henry Schein expands vVARDIS distribution deal for drill-free cavity treatment By Investing.com - Investing.com South Africa
Henry Schein expands exclusive distribution partnership with vVARDIS - TipRanks
Henry Schein, Inc. Expands Partnership with Vvardis - MarketScreener
HSIC Stock Set to Benefit From Henry Schein One's Workflow Launch - Yahoo Finance
Is There Opportunity in Henry Schein After 18% Rally and Digital Dentistry Expansion? - simplywall.st
Henry Schein One to unveil smarter workflows at GNYDM - DrBicuspid.com
Henry Schein’s Sixth Annual ‘Think Pink, Practice Pink’ - Dentistry Today
Henry Schein One unveils natively embedded voice workflow at 2025 Greater New York Dental Meeting - Dental Tribune US
Is Henry Schein Inc. stock a safe investment in uncertain markets2025 Market Overview & Fast Entry High Yield Stock Tips - BỘ NỘI VỤ
HMT Limited Stock Analysis Technical Signals for YEARMACD Trading Signals & You’ve Never Seen Stock Picks Like These - earlytimes.in
Why Henry Schein Inc. stock remains undervaluedJuly 2025 Final Week & Safe Capital Growth Trade Ideas - BỘ NỘI VỤ
Henry Schein (HSIC): Evaluating Valuation After Recent Share Price Rebound - Sahm
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS - The Manila Times
Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting - Business Wire
Peering Into Henry Schein Inc's Recent Short Interest - Benzinga
Henry Schein Is Roaring Back After Its Cyber Attack — Can This Sales Comeback Spark a Major Growth Surge? - Smartkarma
Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know - Finviz
Applying sector rotation models to Henry Schein Inc.Sell Signal & Stock Market Timing Techniques - newser.com
Using flow based indicators on Henry Schein Inc.Long Setup & Real-Time Buy Signal Notifications - newser.com
Will Henry Schein Inc. rebound enough to break evenMarket Trend Report & Growth Focused Entry Reports - newser.com
Henry Schein Inc. stock volume spike explained2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
What risks investors should watch in Henry Schein Inc. stockOptions Play & Risk Controlled Stock Pick Alerts - newser.com
Henry Schein at Jefferies London: Strategic Growth and Leadership Transition - Investing.com India
Transcript : Henry Schein, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 02 - MarketScreener
Key metrics from Henry Schein Inc.’s quarterly dataJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com
Is Henry Schein Inc. stock ready for breakoutInsider Buying & Reliable Breakout Forecasts - newser.com
VP Siegel Files To Sell 4,176 Of Henry Schein Inc [HSIC] - TradingView
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Do Wall Street Analysts Like Henry Schein Stock? - Yahoo Finance
Will Henry Schein Inc. stock attract more institutional investorsTrade Entry Report & AI Forecasted Entry/Exit Points - newser.com
Chart based exit strategy for Henry Schein Inc.Market Weekly Review & Safe Capital Growth Trade Ideas - newser.com
Can Henry Schein Inc. stock hit analyst price targets2025 Earnings Impact & Verified Swing Trading Watchlists - newser.com
What moving averages say about Henry Schein Inc.Risk Management & Community Consensus Stock Picks - newser.com
Henry Schein (HSIC): Fresh Sales Guidance and Strong Earnings Bring Valuation Back Into Focus - Yahoo Finance
What recovery options are there for Henry Schein Inc.Jobs Report & Verified Momentum Stock Ideas - newser.com
What drives Henry Schein Inc stock priceInstitutional Buying Trends & Capitalize On Fast Trends - earlytimes.in
Tools to assess Henry Schein Inc.’s risk profileJuly 2025 Review & Safe Capital Investment Plans - newser.com
Is Henry Schein Inc. stock dividend yield sustainableJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com
Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛
Analyzing drawdowns of Henry Schein Inc. with statistical tools2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.47%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):